How much is a box of Avonib’s latest price in 2024?

Ivosidenib is a targeted drug mainly used to treat patients with acute myeloid leukemia (AML) who carry isocitrate dehydrogenase1 (IDH1) mutations. AML is a severe and rapidly developing leukemia, and IDH1 mutations affect the metabolic process of cancer cells, causing them to continue to proliferate. Ivonib inhibits the activity of IDH1 enzyme and blocks the metabolic pathways of cancer cells, thereby curbing the growth of tumors. This mechanism makes ivonib an important treatment option for patients with IDH1 mutations, especially those who are not suitable for conventional chemotherapy or who are resistant to conventional treatments.

Avosidenib has been launched in China, which means that domestic patients can obtain this advanced treatment solution. However, despite its recognized efficacy, the price of ivonib should not be underestimated. Currently, the drug is not included in the reimbursement scope of the national medical insurance, which requires patients to bear all costs themselves. According to market information, the domestic price of avonib is approximately RMB 30,000 to RMB 40,000 per box. Specific prices may fluctuate depending on the region, hospital and drug purchase channel, so patients are advised to consult their local hospital pharmacy for an accurate quote before purchasing.

For some patients with limited financial conditions, expensive treatment costs may bring a heavy financial burden. In this case, foreign generic drugs have become a more economical choice. Generic ivonib produced in Laos has received widespread attention for its lower price. It is understood that the price of generic drugs in Laos is between 6 and 7,000 yuan, which is significantly lower than the price of domestic original drugs. Despite the obvious price difference, Lao generic drugs are basically the same as the original drugs in terms of ingredients and efficacy, providing patients with an affordable alternative.

In general, ivonib brings new hope to patients with IDH1 mutated cancer, but its high price also requires patients to consider both economic factors and drug efficacy when choosing treatment. For patients who cannot afford the high cost, Lao generic drugs offer a relatively economical alternative. Before deciding on a treatment plan, patients should fully communicate with their doctor and understand all available treatment options.